Alyssa Golden

Characterization of MDR and XDR <i>Streptococcus pneumoniae</i> in Canada, 2007–13

Alyssa Golden, Margot Rosenthal, Ben Fultz et al. · Journal of Antimicrobial Chemotherapy · 2015 · 73 citations · Full text

42936 pathogens from Canadian hospitals: 10 years of results (2007–16) from the CANWARD surveillance study

George G. Zhanel, Heather J. Adam, Melanie Baxter et al. · Journal of Antimicrobial Chemotherapy · 2019 · 66 citations

Analysis of multidrug resistance in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011–15

Heather J. Adam, Alyssa Golden, James A. Karlowsky et al. · Journal of Antimicrobial Chemotherapy · 2018 · 58 citations · Full text

In Vitro Activity of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacilli Isolated from Patients in Canadian Intensive Care Units

Alyssa Golden, Heather J. Adam, Melanie Baxter et al. · Diagnostic Microbiology and Infectious Disease · 2020 · 48 citations

Gram-negative Bacilli Isolated, Health Sciences, Medicine +10

Assessment of multidrug resistance, clonality and virulence in non-PCV-13 <i>Streptococcus pneumoniae</i> serotypes in Canada, 2011–13

Alyssa Golden, Heather J. Adam, Matthew W. Gilmour et al. · Journal of Antimicrobial Chemotherapy · 2015 · 35 citations · Full text